Kapitalisasi Pasar Perubahan Tanggal
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Chugai Pharma JPY 12.65T 1.81T 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novavax USD 1.09B 316M 2025-12
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08